Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study)

NCT00542178 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3472

Enrollment

NIH

Sponsor class

Conditions

Diabetic Retinopathy

Interventions

DRUG: Hypoglycemic Agents
DRUG: Standard glycemia control
DRUG: Intensive BP treatment
DRUG: Standard BP control
DRUG: Fenofibrate
DRUG: Simvastatin
DRUG: Placebo

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborators

[object Object]